PHARMCLO: Multiple Genotyping to Guide Antiplatelet Therapy Significantly Reduced MACE Outcomes at 1 year Among ACS patients By Tarek Nafee, M.D. on March 12, 2018 Download (PPTX, 1.07MB)
Leave a Reply
You must be logged in to post a comment.